Effects of PTEN on the proliferation and apoptosis of colorectal cancer cells via the phosphoinositol-3-kinase/Akt pathway

Oncology Reports

Volumn 33, Issue 4, 2015, Pages 1828-1836

  Sun, Yan ^a   Tian, Hua ^b   Wang, Lin ^c  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c GUANGZHOU RED CROSS HOSPITAL   (China)

Author keywords

Apoptosis; Colorectal cancer cells; PI3K; Proliferation; PTEN

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PTEN PROTEIN, HUMAN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL; CANCER STAGING; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE DELETION; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; COLORECTAL TUMOR; FLOW CYTOMETRY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

ADULT; AGED; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; COLORECTAL NEOPLASMS; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84924872876     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2015.3804     Document Type: Article

References (42)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62: 10-29, 2012.
2. You WC, Jin F, Devesa S, et al: Rapid increase in colorectal cancer rates in urban Shanghai, 1972-97, in relation to dietary changes. J Cancer Epidemiol Prev 7: 143-146, 2002.
3. Cerottini JP, Caplin S, Pampallona S and Givel JC: Prognostic factors in colorectal cancer. Oncol Rep 6: 409-414, 1999.
4. Parsons DW, Wang TL, Samuels Y, et al: Colorectal cancer: mutations in a signalling pathway. Nature 436: 792, 2005.
5. Lee JO, Yang H, Georgescu MM, et al: Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association. Cell 99: 323-334, 1999.
6. Di Cristofano A and Pandolfi PP: The multiple roles of PTEN in tumor suppression. Cell 100: 387-390, 2000.
7. Cully M, You H, Levine AJ and Mak TW: Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 6: 184-192, 2006.
8. Accili D and Arden KC: FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117: 421-426, 2004.
9. Greer EL and Brunet A: FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene 24: 7410-7425, 2005.
10. Brunet A, Bonni A, Zigmond MJ, et al: Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96: 857-868, 1999.
11. Morson BC: The evolution of colorectal carcinoma. Clin Radiol 35: 425-431, 1984.
12. Sherman DW, Ye XY, McSherry C, Parkas V, Calabrese M and Gatto M: Quality of life of patients with advanced cancer and acquired immune deficiency syndrome and their family caregivers. J Palliat Med 9: 948-963, 2006.
13. Zhang SQ: Screening and prevention of colorectal cancer in Haining County. Dis Colon Rectum 28: 300-304, 1985.
14. Zhang SQ, Zhu SX and Wu JM: Screening and prevention of colorectal cancer in Haining county. Chin Med J 93: 843-848, 1980.
15. Stambolic V, Suzuki A, de la Pompa JL, et al: Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell 95: 29-39, 1998.
16. Eng C: PTEN: one gene, many syndromes. Hum Mutat 22: 183-198, 2003.
17. Rustia A, Wierzbicki V, Marrocco L, Tossini A, Zamponi C and Lista F: Is exon 5 of the PTEN/MMAC1 gene a prognostic marker in anaplastic glioma Neurosurg Rev 24: 97-102, 2001.
18. Cheney IW, Neuteboom ST, Vaillancourt MT, Ramachandra M and Bookstein R: Adenovirus-mediated gene transfer of MMAC1/PTEN to glioblastoma cells inhibits S phase entry by the recruitment of p27Kip1 into cyclin E/CDK2 complexes. Cancer Res 59: 2318-2323, 1999.
19. Cantley LC and Neel BG: New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. Proc Natl Acad Sci USA 96: 4240-4245, 1999.
20. Burgering BM and Kops GJ: Cell cycle and death control: long live Forkheads. Trends Biochem Sci 27: 352-360, 2002.
21. Burgering BM and Medema RH: Decisions on life and death: FOXO Forkhead transcription factors are in command when PKB/Akt is off duty. J Leukoc Biol 73: 689-701, 2003.
22. Brownawell AM, Kops GJ, Macara IG and Burgering BM: Inhibition of nuclear import by protein kinase B (Akt) regulates the subcellular distribution and activity of the forkhead transcription factor AFX. Mol Cell Biol 21: 3534-3546, 2001.
23. Shi F and LaPolt PS: Relationship between FoxO1 protein levels and follicular development, atresia, and luteinization in the rat ovary. J Endocrinol 179: 195-203, 2003.
24. Brunet A, Kanai F, Stehn J, et al: 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J Cell Biol 156: 817-828, 2002.
25. Ramaswamy S, Nakamura N, Sansal I, Bergeron L and Sellers WR: A novel mechanism of gene regulation and tumor suppression by the transcription factor FKHR. Cancer Cell 2: 81-91, 2002.
26. Medema RH, Kops GJ, Bos JL and Burgering BM: AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature 404: 782-787, 2000.
27. Kops GJ, Medema RH, Glassford J, et al: Control of cell cycle exit and entry by protein kinase B-regulated forkhead transcription factors. Mol Cell Biol 22: 2025-2036, 2002.
28. Schmidt M, Fernandez de Mattos S, van der Horst A, et al: Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol Cell Biol 22: 7842-7852, 2002.
29. Martinez-Gac L, Marques M, Garcia Z, Campanero MR and Carrera AC: Control of cyclin G2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead. Mol Cell Biol 24: 2181-2189, 2004.
30. Ramaswamy S, Nakamura N, Vazquez F, et al: Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc Natl Acad Sci USA 96: 2110-2115, 1999.
31. Di Cristofano A, De Acetis M, Koff A, Cordon-Cardo C and Pandolfi PP: Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet 27: 222-224, 2001.
32. Zhu X, Kwon CH, Schlosshauer PW, Ellenson LH and Baker SJ: PTEN induces G(1) cell cycle arrest and decreases cyclin D3 levels in endometrial carcinoma cells. Cancer Res 61: 4569-4575, 2001.
33. Weng LP, Brown JL and Eng C: PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model. Hum Mol Genet 10: 599-604, 2001.
34. Wu RC, Li X and Schonthal AH: Transcriptional activation of p21WAF1 by PTEN/MMAC1 tumor suppressor. Mol Cell Biochem 203: 59-71, 2000.
35. Romashkova JA and Makarov SS: NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature 401: 86-90, 1999.
36. Gustin JA, Maehama T, Dixon JE and Donner DB: The PTEN tumor suppressor protein inhibits tumor necrosis factor-induced nuclear factor kappa B activity. J Biol Chem 276: 27740-27744, 2001.
37. Yuan XJ and Whang YE: PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway. Oncogene 21: 319-327, 2002.
38. Huang H, Cheville JC, Pan Y, Roche PC, Schmidt LJ and Tindall DJ: PTEN induces chemosensitivity in PTEN-mutated prostate cancer cells by suppression of Bcl-2 expression. J Biol Chem 276: 38830-38836, 2001.
39. Mayo LD, Dixon JE, Durden DL, Tonks NK and Donner DB: PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J Biol Chem 277: 5484-5489, 2002.
40. Stambolic V, MacPherson D, Sas D, et al: Regulation of PTEN transcription by p53. Mol Cell 8: 317-325, 2001.
41. Reagan-Shaw S and Ahmad N: RNA interference-mediated depletion of phosphoinositide 3-kinase activates forkhead box class O transcription factors and induces cell cycle arrest and apoptosis in breast carcinoma cells. Cancer Res 66: 1062-1069, 2006.
42. Carter JH, Douglass LE, Deddens JA, et al: Pak-1 expression increases with progression of colorectal carcinomas to metastasis. Clin Cancer Res 10: 3448-3456, 2004.